NASDAQ OMX

CrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) Conference

Dela

SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, will showcase their scientific expertise at this year's American Association for Cancer Research's International Conference (AACR) in Chicago, IL on April 14th - 18th.

CrownBio's scientists will present more than a dozen scientific posters describing their latest efforts to revolutionize preclinical development of cancer treatments. These scientific posters will demonstrate the combined power of CrownBio's integrated oncology platform to advance oncology pipelines using their exhaustive patient-derived xenograft (PDX) collection, innovative humanized tumor models and three dimensional ex vivo cultures that recapitulate the in vivo tumor microenvironment. Featured work will show data from novel models that enable precise evaluation of new cancer therapeutics, including bi-specific T-cell engagers (BiTEs), targeted cancer immunotherapies and combinatory immunotherapies.  

"I am excited to share Crown Bioscience's cutting-edge research with colleagues at AACR," said Dr. Henry Li, Crown Bioscience's Vice President of Translational Oncology. "The data presented will exhibit the utility of our clinically relevant solutions to identify critical biomarkers and improve preclinical evaluation of cancer therapies."

"Crown Bioscience is honored to play a leading role in presenting opportunities for scientific advancements at AACR," said Laurie Heilmann, Chief Business Officer. "The work of our dedicated scientific team exemplifies Crown Bioscience's commitment to helping researchers solve global health challenges through continued innovation of our scientific translational platform."

Delegates can request copies of the posters and learn more about Crown Bioscience's scientific translational platform at booth #3012.

About Crown Bioscience Inc.  
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

Media Enquiries:  
Jody Barbeau 
Crown Bioscience Inc. 
marketing@CrownBioscience.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Crown Bioscience Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Forterra Announces First Quarter 2018 Earnings Schedule24.4.2018 12:00Pressmeddelande

IRVING, Texas, April 24, 2018 (GLOBE NEWSWIRE) -- Forterra, Inc. ("Forterra") (Nasdaq:FRTA) plans to release first quarter 2018 financial results before the market open on Tuesday, May 8, 2018. A conference call to review financial results will also be held on Tuesday, May 8, 2018 at 8:30 a.m. Eastern time (7:30 a.m. Central). Hosting the call will be Jeff Bradley, Chief Executive Officer, and Charlie Brown, Executive Vice President and Chief Financial Officer. CONFERENCE CALL AND WEBCAST DETAILS Webcast Information Event: Q1 2018 Forterra, Inc. Earnings Call Date: Tuesday, May 8, 2018 Time: 8:30 a.m. Eastern Time (7:30 a.m. Central) https://edge.media-server.com/m6/p/a3wzhe79 Conference Call Information U.S.: 1-574-990-1396 Toll-Free: 1-844-498-0572 Participant Passcode: 6398379 Replay Information A replay of the conference call and archive of the webcast will be available within 24 hours after the call on the "Events & Presentations" page under the Investor section of the Company's w

Meltwater acquires leading social analytics company Sysomos24.4.2018 10:00Pressmeddelande

Acquisition expands Meltwater's ability to incorporate online news and data with social media analytics in one robust platform SAN FRANCISCO, April 24, 2018 (GLOBE NEWSWIRE) -- Meltwater, a pioneer of media intelligence and now Outside Insight, today announced its acquisition of Sysomos, a leader in social analytics and engagement. The addition of Sysomos to Meltwater enables organizations to analyze social media, news and other human-generated content in one platform, furthering Meltwater's mission to give businesses the insights from outside data, helping them stay ahead. "All the social analytics companies look at social data in isolation, limiting the insights for brands and businesses," says Jorn Lyseggen, founder and CEO of Meltwater. "With our acquisition of Sysomos, we can bring together news and social media under one company, giving social data context while adding social engagement to our news and media monitoring offering." For the PR and communications teams who engage wit

New leaders emerge in 2018 All-Europe trading team ranking24.4.2018 10:00Pressmeddelande

NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- Competition in electronic trading is becoming fierce as global trade execution teams re-position themselves for delivering their solutions at scale in a post MiFID II regulatory environment. J.P. Morgan continues to dominate claiming first place in electronic trading, for a second consecutive year, according to Institutional Investor's All-Europe Trading Team survey. Meanwhile Bank of America Merrill Lynch took home second place, up two spots from fourth place last year; a significant move for Bank of America Merrill Lynch, which bumped its peers Credit Suisse in third place and UBS in fourth place to win the No. 2 position. The two-rung move is a marked shift away from its previous high-touch leadership and is an endorsement that the bank's investments in technology are resonating with clients. In high-touch trading, UBS leapt to No. 1 swapping its fifth place position last year with Bank of America Merrill Lynch, who took fifth in the high

BT Dials in Corvil Analytics to Help Achieve World-Class Service Delivery for World's Largest Virtual Contact Centre24.4.2018 10:00Pressmeddelande

Corvil empowers BT with the visibility and insight to achieve outstanding caller experience for a public sector customer serving 20M+ citizens DUBLIN, Ireland, April 24, 2018 (GLOBE NEWSWIRE) -- Corvil today announced that BT Global Services has deployed Corvil Analytics to manage and optimise VoIP call quality of one of the largest contact centres in the world channelling its services through 30,000 agents across 180 sites. As a leading provider of contact centre solutions globally, BT has a strong track-record in designing and implementing large-scale transformational engagements. Looking to simplify service assurance and maintain call quality excellence in an environment where call volumes continually reach 12500 concurrent calls (12 new calls per second), BT sought to enlist an analytics partner. In a climate of intense scrutiny on public sector performance and with stringent customer Service Level Agreements (SLAs) in place, BT selected Corvil to help improve caller experience by

MedicCoin Unveils International Adoption Strategy Based on Integrating Blockchain Technology into Everyday Life24.4.2018 09:00Pressmeddelande

Strategy focuses on improving health of mankind through blockchain-powered rewards, advancing scientific research and charitable donations NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- MedicCoin, a community-driven crypto focused on improving the lives of millions worldwide, today provides the multifaceted roadmap established for global adoption while recapping practical innovations that set MedicCoin apart for everyday use. Introducing Multiple Ways to Earn Crypto as a Reward for Positive Choices The MedicCoin founders envisioned using blockchain technology to make life better for all mankind. A key part of staying true to this vision is ensuring people around the world can join the MedicCoin community without highly technical skills or expensive mining equipment. Living an Active Lifestyle By simply installing the MedicWalk app and staying active, anyone will be able to acquire MedicCoin. MedicWalk will be launched within the next few weeks. Donating Unused Computer

In-Memory Computing Summit Europe Announces Full Breakout Session Schedule24.4.2018 09:00Pressmeddelande

Register by April 29th to Receive a 30 Percent Discount FOSTER CITY, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- GridGain Systems, provider of enterprise-grade in-memory computing platform solutions based on Apache® Ignite(TM), today released the full breakout session schedule for the second annual In-Memory Computing Summit® Europe, the premier conference for individuals from Europe and Asia that are currently using or exploring using in-memory computing. Conference breakout sessions are in five tracks: Tales from the Trenches, New Capabilities, Architecture, Streaming Data, and Hardware. Speakers include representatives from companies such as Oracle, Intel, NEC Corporation of America, GridGain Systems, Hazelcast, iguazio, Neeve Research, ScaleOut Software, Software AG, Bouquet.ai, and VoltDB. The IMC Summit Europe will take place at the Park Plaza Victoria London, June 25-26, 2018. Attendees can receive a 30 percent Super Saver discount off the full price registration fee by purchasin

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum